About Align Technology, Inc. - Common Stock (ALGN)
Align Technology is a medical device company known primarily for its innovative dental products, including the Invisalign system, which offers a clear alternative to traditional metal braces for orthodontic treatment. The company focuses on transforming patients' smiles through advanced 3D computer modeling and digital scanning technologies, enabling customized treatment plans. In addition to its flagship product, Align Technology also produces a range of other tools and software that enhance dental practice efficiency and patient care, serving both orthodontists and general dentists. By combining cutting-edge technology with a commitment to improving oral health, Align Technology aims to empower patients and revolutionize the field of orthodontics. Read More
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Align Technology shares are tumbling in Wednesday's after-hours session after the company reported worse-than-expected results for the second quarter and issued soft guidance.
Dental technology company Align Technology (NASDAQ:ALGN) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 1.6% year on year to $1.01 billion. Next quarter’s revenue guidance of $975 million underwhelmed, coming in 6.4% below analysts’ estimates. Its non-GAAP profit of $2.49 per share was 3.3% below analysts’ consensus estimates.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter ("Q2'25"). Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year. Q2'25 total revenues were favorably impacted by foreign exchange of approximately $26.4 million, or 2.7% sequentially, and favorably impacted by approximately $5.6 million, or 0.6% year-over-year.(1) Q2'25 Clear Aligner revenues were $804.6 million, up 1.0% sequentially and down 3.3% year-over-year. Q2'25 Clear Aligner revenues were favorably impacted by foreign exchange of approximately $21.6 million, or 2.8% sequentially, and favorably impacted by approximately $4.5 million, or 0.6% year-over-year. Q2'25 Clear Aligner volume was up 0.3% sequentially and year-over-year. Q2'25 Imaging Systems and CAD/CAM Services revenues were $207.8 million, up 13.9% sequentially, and up 5.6% year-over-year. Q2'25 Imaging Systems and CAD/CAM Services revenues were favorably impacted by foreign exchange of approximately $4.8 million, or 2.3% sequentially and favorably impacted by approximately $1.0 million, or 0.5% year-over-year.(1)
Dental technology company Align Technology (NASDAQ:ALGN)
will be announcing earnings results this Wednesday after market hours. Here’s what investors should know.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
